Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bxl-628
2. Bxl628
1. 199798-84-0
2. Bxl 628
3. Elocalcitol [inn]
4. Bxl-628
5. Ro-26-9228
6. 2wds5f2v6q
7. Ro 26-9228
8. (1r,3z,5s)-3-[(2e)-2-[(3as,7as)-1-[(e,2s)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3h-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol
9. Bxl628
10. Unii-2wds5f2v6q
11. Elocalcitol [mart.]
12. Gtpl2785
13. Schembl12932254
14. Zha79884
15. Zinc4802676
16. 1alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epi-cholecalciferol
17. Akos025312296
18. Db06194
19. Hy-32345
20. Cs-0001526
21. J3.510.012a
22. E98793
23. 798e840
24. Q27077174
25. 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3
26. (1r,5s,z)-3-((e)-2-((3as,7as)-3-((s,e)-6-ethyl-6-hydroxyoct-4-en-2-yl)-3a-methyl-3a,4,5,6-tetrahydro-1h-inden-7(7ah)-ylidene)ethylidene)-5-fluoro-4-methylenecyclohexanol
27. 1s,3r,5z,7e,23e)-1-fluoro-26,27-dihomo-9,10-secocholesta-5,7,10(19),16,23-pentaene-3,25-diol
28. Cyclohexanol, 3-((1-(5-ethyl-5-hydroxy-1-methyl-3-heptenyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-5-fluoro-4-methylene-, (3as-(1(1r*,3e),3aalpha,4e(1s*,3z,5r*),7abeta))-
29. Cyclohexanol, 3-((2e)-((3as,7as)-1-((1s,3e)-5-ethyl-5-hydroxy-1-methyl-3-heptenyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-5-fluoro-4-methylene-, (1r,3z,5s)-
| Molecular Weight | 442.6 g/mol |
|---|---|
| Molecular Formula | C29H43FO2 |
| XLogP3 | 5.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | 442.32470877 g/mol |
| Monoisotopic Mass | 442.32470877 g/mol |
| Topological Polar Surface Area | 40.5 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 813 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 3 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in benign prostatic hyperplasia, urinary incontinence, prostate disorders, and infertility.
Treatment of benign prostatic hyperplasia
ABOUT THIS PAGE
A Elocalcitol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elocalcitol, including repackagers and relabelers. The FDA regulates Elocalcitol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elocalcitol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elocalcitol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Elocalcitol supplier is an individual or a company that provides Elocalcitol active pharmaceutical ingredient (API) or Elocalcitol finished formulations upon request. The Elocalcitol suppliers may include Elocalcitol API manufacturers, exporters, distributors and traders.
click here to find a list of Elocalcitol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Elocalcitol DMF (Drug Master File) is a document detailing the whole manufacturing process of Elocalcitol active pharmaceutical ingredient (API) in detail. Different forms of Elocalcitol DMFs exist exist since differing nations have different regulations, such as Elocalcitol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Elocalcitol DMF submitted to regulatory agencies in the US is known as a USDMF. Elocalcitol USDMF includes data on Elocalcitol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Elocalcitol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Elocalcitol suppliers with USDMF on PharmaCompass.
Elocalcitol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elocalcitol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elocalcitol GMP manufacturer or Elocalcitol GMP API supplier for your needs.
A Elocalcitol CoA (Certificate of Analysis) is a formal document that attests to Elocalcitol's compliance with Elocalcitol specifications and serves as a tool for batch-level quality control.
Elocalcitol CoA mostly includes findings from lab analyses of a specific batch. For each Elocalcitol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elocalcitol may be tested according to a variety of international standards, such as European Pharmacopoeia (Elocalcitol EP), Elocalcitol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elocalcitol USP).
LOOKING FOR A SUPPLIER?
